These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 18071659)

  • 21. Toll-like receptors and innate immunity.
    Kumar H; Kawai T; Akira S
    Biochem Biophys Res Commun; 2009 Oct; 388(4):621-5. PubMed ID: 19686699
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activation of dendritic cells by toll-like receptors and C-type lectins.
    Diebold SS
    Handb Exp Pharmacol; 2009; (188):3-30. PubMed ID: 19031019
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Innate signaling and regulation of Dendritic cell immunity.
    van Vliet SJ; den Dunnen J; Gringhuis SI; Geijtenbeek TB; van Kooyk Y
    Curr Opin Immunol; 2007 Aug; 19(4):435-40. PubMed ID: 17629469
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential detergent fractionation for non-electrophoretic bovine peripheral blood monocyte proteomics reveals proteins involved in professional antigen presentation.
    Lee SR; Pharr GT; Cooksey AM; McCarthy FM; Boyd BL; Pinchuk LM
    Dev Comp Immunol; 2006; 30(11):1070-83. PubMed ID: 16566999
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression and role of Fc- and complement-receptors on human dendritic cells.
    Bajtay Z; Csomor E; Sándor N; Erdei A
    Immunol Lett; 2006 Apr; 104(1-2):46-52. PubMed ID: 16448704
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Activation of Toll-like receptors and dendritic cells by a broad range of bacterial molecules.
    Boele LC; Bajramovic JJ; de Vries AM; Voskamp-Visser IA; Kaman WE; van der Kleij D
    Cell Immunol; 2009; 255(1-2):17-25. PubMed ID: 18926526
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impaired cytokine response in myeloid dendritic cells in chronic hepatitis C virus infection regardless of enhanced expression of Toll-like receptors and retinoic acid inducible gene-I.
    Miyazaki M; Kanto T; Inoue M; Itose I; Miyatake H; Sakakibara M; Yakushijin T; Kakita N; Hiramatsu N; Takehara T; Kasahara A; Hayashi N
    J Med Virol; 2008 Jun; 80(6):980-8. PubMed ID: 18428149
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Platelets "Toll-like receptor" engagement stimulates the release of immunomodulating molecules].
    Cognasse F; Hamzeh-Cognasse H; Garraud O
    Transfus Clin Biol; 2008 Sep; 15(4):139-47. PubMed ID: 18842435
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Toll-like receptors: emerging concepts in kidney disease.
    Anders HJ; Schlöndorff D
    Curr Opin Nephrol Hypertens; 2007 May; 16(3):177-83. PubMed ID: 17420659
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Murine [corrected] myeloid dendritic cell-dependent toll-like receptor immunity is preserved with aging.
    Tesar BM; Walker WE; Unternaehrer J; Joshi NS; Chandele A; Haynes L; Kaech S; Goldstein DR
    Aging Cell; 2006 Dec; 5(6):473-86. PubMed ID: 17129212
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pathogens use carbohydrates to escape immunity induced by dendritic cells.
    van Kooyk Y; Engering A; Lekkerkerker AN; Ludwig IS; Geijtenbeek TB
    Curr Opin Immunol; 2004 Aug; 16(4):488-93. PubMed ID: 15245744
    [TBL] [Abstract][Full Text] [Related]  

  • 32. T cell-dependent and -independent IgA responses: role of TLR signalling.
    Bessa J; Bachmann MF
    Immunol Invest; 2010; 39(4-5):407-28. PubMed ID: 20450285
    [TBL] [Abstract][Full Text] [Related]  

  • 33. C-type lectins on dendritic cells: key modulators for the induction of immune responses.
    van Kooyk Y
    Biochem Soc Trans; 2008 Dec; 36(Pt 6):1478-81. PubMed ID: 19021579
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Innate immunity and tuberculosis].
    Uematsu S; Akira S
    Kekkaku; 2008 Feb; 83(2):101-9. PubMed ID: 18326337
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Strategies for recruiting and targeting dendritic cells for optimizing HIV vaccines.
    Ahlers JD; Belyakov IM
    Trends Mol Med; 2009 Jun; 15(6):263-74. PubMed ID: 19487159
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fundamental mechanisms of host immune responses to infection.
    Azuma M
    J Periodontal Res; 2006 Oct; 41(5):361-73. PubMed ID: 16953812
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Toll-like receptors and control of mycobacterial infection in mice.
    Ryffel B; Jacobs M; Parida S; Botha T; Togbe D; Quesniaux V
    Novartis Found Symp; 2006; 279():127-39; discussion 139-41, 216-9. PubMed ID: 17278391
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Systemic activation of dendritic cells by Toll-like receptor ligands or malaria infection impairs cross-presentation and antiviral immunity.
    Wilson NS; Behrens GM; Lundie RJ; Smith CM; Waithman J; Young L; Forehan SP; Mount A; Steptoe RJ; Shortman KD; de Koning-Ward TF; Belz GT; Carbone FR; Crabb BS; Heath WR; Villadangos JA
    Nat Immunol; 2006 Feb; 7(2):165-72. PubMed ID: 16415871
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The investigations of the role of toll-like receptors (TLR) in host response to parasitic infection on the current background regarding TLR in mammals and the model nematode Caenorhabditis elegans].
    Wojtkowiak A
    Wiad Parazytol; 2007; 53(3):203-11. PubMed ID: 18075152
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Toll like receptors and acute allograft rejection.
    Goldstein DR
    Transpl Immunol; 2006 Dec; 17(1):11-5. PubMed ID: 17157206
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.